Clinical Trial Update: Melatonin for Treatment of Delirium in Critically Ill Adult Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating melatonin as a treatment for delirium in critically ill adult patients. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Ciusss de L'Est de l'Île de Montréal | Conditions: Delirium | Phase 2 | Status: RECRUITING